|Other Names||Serine/threonine-protein kinase 17B, DAP kinase-related apoptosis-inducing protein kinase 2, STK17B, DRAK2|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Phosphorylates myosin light chains (By similarity). Acts as a positive regulator of apoptosis.|
|Cellular Location||Nucleus. Cell membrane. Endoplasmic reticulum-Golgi intermediate compartment. Note=Colocalizes with STK17B at the plasma membrane.|
|Tissue Location||Highly expressed in placenta, lung, pancreas. Lower levels in heart, brain, liver, skeletal muscle and kidney|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
STK17B acts as a positive regulator of apoptosis.
Rose, J. Phd, et al. Mol. Med. (2010) In press :Landa, I., et al. PLoS Genet. 5 (9), E1000637 (2009) :Doherty, G.A., et al. Br. J. Cancer 101(3):483-491(2009)Gatzka, M., et al. J. Immunol. 183(1):285-297(2009)Friedrich, M.L., et al. J. Biol. Chem. 282(7):4573-4584(2007)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.